Schizophrenia laboratory findings
|
Schizophrenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Schizophrenia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Schizophrenia laboratory findings |
|
Risk calculators and risk factors for Schizophrenia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2], Irfan Dotani
Overview
An initial assessment includes a comprehensive history and physical examination by a physician. Although there are no biological tests which confirm schizophrenia, tests are carried out to exclude medical illnesses which may rarely present with psychotic schizophrenia-like symptoms. These include blood tests measuring TSH to exclude hypo- or hyperthyroidism, basic electrolytes and serum calcium to rule out a metabolic disturbance, full blood count including ESR to rule out a systemic infection or chronic disease, and serology to exclude syphilis or HIV infection. Drugs of abuse should also be tested for with a urine drug screen, and further diagnostic workup is detailed here.
Laboratory Findings
- An initial assessment includes a comprehensive history and physical examination by a physician.[1]
- Although there are no biological tests which confirm schizophrenia, tests are carried out to exclude medical illnesses which may rarely present with psychotic schizophrenia-like symptoms.[2]
- These include blood tests measuring TSH to exclude hypo- or hyperthyroidism, basic electrolytes and serum calcium to rule out a metabolic disturbance, full blood count including ESR to rule out a systemic infection or chronic disease, and serology to exclude syphilis or HIV infection.
- Drugs of abuse should also be tested for with a urine drug screen, and further diagnostic workup is detailed here.[3]
- Investigations are not generally repeated for relapse unless there is a specific medical indication.[4]
- These may include serum blood sugar level if olanzapine has previously been prescribed, liver function tests if chlorpromazine or CPK to exclude neuroleptic malignant syndrome.
- Assessment and treatment are usually done on an outpatient basis; admission to an inpatient facility is considered if there is a risk to self or others.
References
- ↑ Dougall N, Maayan N, Soares-Weiser K, McDermott LM, McIntosh A (2015). "Transcranial magnetic stimulation (TMS) for schizophrenia". Cochrane Database Syst Rev (8): CD006081. doi:10.1002/14651858.CD006081.pub2. PMID 26289586.
- ↑ Tandon R, Keshavan MS, Nasrallah HA (2008). "Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview". Schizophr Res. 100 (1–3): 4–19. doi:10.1016/j.schres.2008.01.022. PMID 18291627.
- ↑ Gorczynski P, Faulkner G (2010). "Exercise therapy for schizophrenia". Cochrane Database Syst Rev (5): CD004412. doi:10.1002/14651858.CD004412.pub2. PMC 4164954. PMID 20464730.
- ↑ Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G; et al. (2012). "Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis". Lancet. 379 (9831): 2063–71. doi:10.1016/S0140-6736(12)60239-6. PMID 22560607. Review in: Evid Based Ment Health. 2012 Nov;15(4):92